The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer

<p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with a...

Full description

Bibliographic Details
Main Authors: Hopkins, T, Mura, M, Al-Ashtal, H, Lahr, R, Abd-Latip, N, Sweeney, K, Lu, H, Weir, J, El-Bahrawy, M, Steel, J, Ghaem-Maghami, S, Aboagye, E, Berman, A, Blagden, S
Format: Journal article
Language:English
Published: Oxford University Press 2015
_version_ 1797050665019637760
author Hopkins, T
Mura, M
Al-Ashtal, H
Lahr, R
Abd-Latip, N
Sweeney, K
Lu, H
Weir, J
El-Bahrawy, M
Steel, J
Ghaem-Maghami, S
Aboagye, E
Berman, A
Blagden, S
author_facet Hopkins, T
Mura, M
Al-Ashtal, H
Lahr, R
Abd-Latip, N
Sweeney, K
Lu, H
Weir, J
El-Bahrawy, M
Steel, J
Ghaem-Maghami, S
Aboagye, E
Berman, A
Blagden, S
author_sort Hopkins, T
collection OXFORD
description <p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with adverse prognosis. LARP1 associates with an mRNA interactome that is enriched for oncogenic transcripts. Here we explore the role of LARP1 in epithelial ovarian cancer, a disease characterized by the rapid acquisition of resistance to chemotherapy through the induction of pro-survival signalling. We show, using ovarian cell lines and xenografts, that LARP1 is required for cancer cell survival and chemotherapy resistance. LARP1 promotes tumour formation in vivo and maintains cancer stem cell-like populations. Using transcriptomic analysis following LARP1 knockdown, cross-referenced against the LARP1 interactome, we identify BCL2 and BIK as LARP1 mRNA targets. We demonstrate that, through an interaction with the 3′ untranslated regions (3′ UTRs) of BCL2 and BIK, LARP1 stabilizes BCL2 but destabilizes BIK with the net effect of resisting apoptosis. Together, our data indicate that by differentially regulating the stability of a selection of mRNAs, LARP1 promotes ovarian cancer progression and chemotherapy resistance. </p>
first_indexed 2024-03-06T18:08:32Z
format Journal article
id oxford-uuid:02398593-4478-40cf-8821-4c5338857a8c
institution University of Oxford
language English
last_indexed 2024-03-06T18:08:32Z
publishDate 2015
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:02398593-4478-40cf-8821-4c5338857a8c2022-03-26T08:39:32ZThe RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:02398593-4478-40cf-8821-4c5338857a8cEnglishSymplectic Elements at OxfordOxford University Press2015Hopkins, TMura, MAl-Ashtal, HLahr, RAbd-Latip, NSweeney, KLu, HWeir, JEl-Bahrawy, MSteel, JGhaem-Maghami, SAboagye, EBerman, ABlagden, S <p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with adverse prognosis. LARP1 associates with an mRNA interactome that is enriched for oncogenic transcripts. Here we explore the role of LARP1 in epithelial ovarian cancer, a disease characterized by the rapid acquisition of resistance to chemotherapy through the induction of pro-survival signalling. We show, using ovarian cell lines and xenografts, that LARP1 is required for cancer cell survival and chemotherapy resistance. LARP1 promotes tumour formation in vivo and maintains cancer stem cell-like populations. Using transcriptomic analysis following LARP1 knockdown, cross-referenced against the LARP1 interactome, we identify BCL2 and BIK as LARP1 mRNA targets. We demonstrate that, through an interaction with the 3′ untranslated regions (3′ UTRs) of BCL2 and BIK, LARP1 stabilizes BCL2 but destabilizes BIK with the net effect of resisting apoptosis. Together, our data indicate that by differentially regulating the stability of a selection of mRNAs, LARP1 promotes ovarian cancer progression and chemotherapy resistance. </p>
spellingShingle Hopkins, T
Mura, M
Al-Ashtal, H
Lahr, R
Abd-Latip, N
Sweeney, K
Lu, H
Weir, J
El-Bahrawy, M
Steel, J
Ghaem-Maghami, S
Aboagye, E
Berman, A
Blagden, S
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title_full The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title_fullStr The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title_full_unstemmed The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title_short The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
title_sort rna binding protein larp1 is a post transcriptional regulator of survival and tumorigenesis in ovarian cancer
work_keys_str_mv AT hopkinst thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT muram thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT alashtalh thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT lahrr thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT abdlatipn thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT sweeneyk thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT luh thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT weirj thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT elbahrawym thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT steelj thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT ghaemmaghamis thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT aboagyee thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT bermana thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT blagdens thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT hopkinst rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT muram rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT alashtalh rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT lahrr rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT abdlatipn rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT sweeneyk rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT luh rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT weirj rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT elbahrawym rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT steelj rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT ghaemmaghamis rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT aboagyee rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT bermana rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer
AT blagdens rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer